ALPRESS L.P. 2,5 mg, comprimé osmotique à libération prolongée — plaquette(s) PVC-Aluminium de 30 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400933117757 -
CIP7
3311775 -
CIS
69537839
What the source publishes
- Holder
- PFIZER HOLDING FRANCE
- Active ingredients
- PRAZOSINE (CHLORHYDRATE DE), PRAZOSINE BASE
- Form
- comprimé osmotique
- Package
- plaquette(s) PVC-Aluminium de 30 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration d'arrêt de commercialisation
- Authorised on
- 1988-06-22
- Prescription
- Prescription or restricted
Names this record is found by
- ALPRESS L.P. 2,5 mg, comprimé osmotique à libération prolongée — plaquette(s) PVC-Aluminium de 30 comprimé(s)
- ALPRESS L.P. 2,5 mg, comprimé osmotique à libération prolongée
- PRAZOSINE (CHLORHYDRATE DE)
- PRAZOSINE BASE
Complete source data
{
"cis": "69537839",
"cip7": "3311775",
"form": "comprimé osmotique",
"name": "ALPRESS L.P. 2,5 mg, comprimé osmotique à libération prolongée — plaquette(s) PVC-Aluminium de 30 comprimé(s)",
"cip13": "3400933117757",
"holder": "PFIZER HOLDING FRANCE",
"routes": [
"orale"
],
"holders": [
"PFIZER HOLDING FRANCE"
],
"currency": "EUR",
"marketed": false,
"bdmStatus": "Warning disponibilité",
"useDomain": "unknown",
"publicPrice": "9.83",
"authorisedOn": "1988-06-22",
"compositions": [
{
"name": "PRAZOSINE (CHLORHYDRATE DE)",
"nature": "SA",
"strength": "3,01 mg",
"linkageNumber": "1",
"substanceCode": "00859",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "PRAZOSINE BASE",
"nature": "FT",
"strength": "2,50 mg",
"linkageNumber": "1",
"substanceCode": "53450",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "1.02",
"medicinePrice": "8.81",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "ALPRESS L.P. 2,5 mg, comprimé osmotique à libération prolongée",
"marketingStatus": "Déclaration d'arrêt de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "plaquette(s) PVC-Aluminium de 30 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65%"
],
"marketingDeclaredOn": "2025-09-01",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"PRAZOSINE (CHLORHYDRATE DE)",
"PRAZOSINE BASE"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400933117757"